{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T02:18:09Z","timestamp":1768789089145,"version":"3.49.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.cld.2012.03.002","type":"journal-article","created":{"date-parts":[[2012,4,25]],"date-time":"2012-04-25T00:20:29Z","timestamp":1335313229000},"page":"231-245","source":"Crossref","is-referenced-by-count":65,"title":["Drug-Induced Liver Disease"],"prefix":"10.1016","volume":"16","author":[{"given":"Timothy J.","family":"Davern","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.cld.2012.03.002_bib1","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1056\/NEJMra052270","article-title":"Drug-related hepatotoxicity","volume":"354","author":"Navarro","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.cld.2012.03.002_bib2","doi-asserted-by":"crossref","first-page":"947","DOI":"10.7326\/0003-4819-137-12-200212170-00007","article-title":"Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States","volume":"137","author":"Ostapowicz","year":"2002","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.cld.2012.03.002_bib3","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1002\/hep.22332","article-title":"What is idiosyncratic hepatotoxicity? What is it not?","volume":"47","author":"Senior","year":"2008","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2012.03.002_bib4","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1002\/hep.22272","article-title":"Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: search for signals","volume":"47","author":"Lammert","year":"2008","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2012.03.002_bib5","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/hep.21095","article-title":"Drug-induced liver injury: summary of a single topic clinical research conference","volume":"43","author":"Watkins","year":"2006","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2012.03.002_bib6","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1001\/jama.1995.03520300063038","article-title":"Chaparral ingestion. The broadening spectrum of liver injury caused by herbal medications","volume":"273","author":"Gordon","year":"1995","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.cld.2012.03.002_bib7","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.cld.2007.06.002","article-title":"Drug hepatotoxicity from a regulatory perspective","volume":"11","author":"Senior","year":"2007","journal-title":"Clin Liver Dis"},{"issue":"5","key":"10.1016\/j.cld.2012.03.002_bib8","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/ajg.2009.76","article-title":"Drug-induced liver injury in clinical trials: as rare as hens' teeth","volume":"104","author":"Davern","year":"2009","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.cld.2012.03.002_bib9","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0002-9343(02)01529-2","article-title":"Troglitazone-induced liver failure: a case study","volume":"114","author":"Graham","year":"2003","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.cld.2012.03.002_bib10","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrd1750","article-title":"Idiosyncratic drug hepatotoxicity","volume":"4","author":"Kaplowitz","year":"2005","journal-title":"Nat Rev Drug Discov"},{"issue":"12","key":"10.1016\/j.cld.2012.03.002_bib11","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1124\/dmd.31.12.1499","article-title":"Acetaminophen-induced hepatotoxicity","volume":"31","author":"James","year":"2003","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"10.1016\/j.cld.2012.03.002_bib12","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1053\/j.gastro.2006.03.045","article-title":"c-Jun N-terminal kinase plays a major role in murine acetaminophen hepatotoxicity","volume":"131","author":"Gunawan","year":"2006","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.cld.2012.03.002_bib13","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/ng.379","article-title":"HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin","volume":"41","author":"Daly","year":"2009","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.cld.2012.03.002_bib14","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1053\/j.gastro.2011.04.001","article-title":"Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles","volume":"141","author":"Lucena","year":"2011","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.cld.2012.03.002_bib15","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1053\/j.gastro.2010.06.007","article-title":"Keratin variants predispose to acute liver failure and adverse outcome: race and ethnic associations","volume":"139","author":"Strnad","year":"2010","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.cld.2012.03.002_bib16","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/hep.23720","article-title":"Pharmacogenetics of drug-induced liver injury","volume":"52","author":"Russmann","year":"2010","journal-title":"Hepatology"},{"issue":"13","key":"10.1016\/j.cld.2012.03.002_bib17","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1001\/jama.1994.03510370044030","article-title":"Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease","volume":"271","author":"Watkins","year":"1994","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.cld.2012.03.002_bib18","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1002\/hep.20948","article-title":"Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study","volume":"42","author":"Larson","year":"2005","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2012.03.002_bib19","first-page":"1021","article-title":"Acetaminophen hepatotoxicity","volume":"40","author":"Davern","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2012.03.002_bib20","unstructured":"Available at: http:\/\/www.kqed.org\/epArchive\/R510310737. Accessed March 3, 2012."},{"key":"10.1016\/j.cld.2012.03.002_bib21","unstructured":"Available at: http:\/\/www.sfgate.com\/cgi-bin\/article.cgi?f=\/c\/a\/2004\/08\/15\/EDGFT87DK31.DTL. Accessed March 3, 2012."},{"key":"10.1016\/j.cld.2012.03.002_bib22","unstructured":"Available at: http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm239894.htm. Accessed March 3, 2012."},{"issue":"6","key":"10.1016\/j.cld.2012.03.002_bib23","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1053\/j.gastro.2008.09.011","article-title":"Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States","volume":"135","author":"Chalasani","year":"2008","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.cld.2012.03.002_bib24","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1067\/mcp.2000.106574","article-title":"Ethanol and production of the hepatotoxic metabolite of acetaminophen in healthy adults","volume":"67","author":"Thummel","year":"2000","journal-title":"Clin Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.cld.2012.03.002_bib25","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1053\/j.gastro.2010.04.001","article-title":"Risk factors for idiosyncratic drug-induced liver injury","volume":"138","author":"Chalasani","year":"2010","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.cld.2012.03.002_bib26","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/j.1365-2036.2008.03822.x","article-title":"The use of potentially hepatotoxic drugs in patients with liver disease","volume":"28","author":"Gupta","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.cld.2012.03.002_bib27","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1053\/j.gastro.2004.02.015","article-title":"Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity","volume":"126","author":"Chalasani","year":"2004","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.cld.2012.03.002_bib28","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0168-8278(90)90124-A","article-title":"Criteria of drug-induced liver disorders. Report of an international consensus meeting","volume":"11","author":"B\u00e9nichou","year":"1990","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2012.03.002_bib29","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1053\/jhep.2001.21083","article-title":"Causality assessment versus guilt-by-association in drug hepatotoxicity","volume":"33","author":"Kaplowitz","year":"2001","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2012.03.002_bib30","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/hep.22442","article-title":"Reliability of the Roussel Uclaf Causality Assessment Method for assessing causality in drug-induced liver injury","volume":"48","author":"Rochon","year":"2008","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2012.03.002_bib31","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1002\/hep.23577","article-title":"US Drug-Induced Liver Injury Network. Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method","volume":"51","author":"Rockey","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2012.03.002_bib32","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S1473-3099(08)70255-X","article-title":"Hepatitis E: an emerging infection in developed countries","volume":"8","author":"Dalton","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cld.2012.03.002_bib33","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jhep.2007.12.008","article-title":"Hepatitis E: an emerging awareness of an old disease","volume":"48","author":"Purcell","year":"2008","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2012.03.002_bib34","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1086\/599319","article-title":"Epidemiology of hepatitis E virus in the United States: results from the Third National Health and Nutrition Examination Survey, 1988-1994","volume":"200","author":"Kuniholm","year":"2009","journal-title":"J\u00a0Infect Dis"},{"issue":"Pt 9","key":"10.1016\/j.cld.2012.03.002_bib35","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1099\/vir.0.19242-0","article-title":"Sporadic acute or fulminant hepatitis E in Hokkaido, Japan, may be food-borne, as suggested by the presence of hepatitis E virus in pig liver as food","volume":"84","author":"Yazaki","year":"2003","journal-title":"J\u00a0Gen Virol"},{"key":"10.1016\/j.cld.2012.03.002_bib36","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1086\/378074","article-title":"Severe hepatitis E virus infection after ingestion of uncooked liver from a wild boar","volume":"188","author":"Matsuda","year":"2003","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cld.2012.03.002_bib37","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1086\/593211","article-title":"Phylogenetic and case-control study on hepatitis E virus infection in Germany","volume":"198","author":"Wichmann","year":"2008","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cld.2012.03.002_bib38","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1111\/j.1365-2036.2007.03504.x","article-title":"The role of hepatitis E virus testing in drug-induced liver injury","volume":"26","author":"Dalton","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cld.2012.03.002_bib39","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1572-0241.2006.00416.x","article-title":"Epidemiology and clinical features of sporadic hepatitis E as compared with hepatitis A","volume":"101","author":"Chau","year":"2006","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.cld.2012.03.002_bib40","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1053\/j.gastro.2011.07.051","article-title":"Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury","volume":"141","author":"Davern","year":"2011","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.cld.2012.03.002_bib41","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1053\/j.gastro.2006.01.033","article-title":"Measurement of serum acetaminophen-protein adducts in patients with acute liver failure","volume":"130","author":"Davern","year":"2006","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.cld.2012.03.002_bib42","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/hep.20081","article-title":"Hy's law","volume":"39","author":"Reuben","year":"2004","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2012.03.002_bib43","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/hep.20800","article-title":"Outcome and prognostic markers in severe drug-induced liver disease","volume":"42","author":"Bj\u00f6rnsson","year":"2005","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2012.03.002_bib44","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/pds.1210","article-title":"How can \u2018Hy's law\u2019 help the clinician?","volume":"15","author":"Senior","year":"2006","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6","key":"10.1016\/j.cld.2012.03.002_bib45","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1002\/hep.21424","article-title":"Outcome of acute idiosyncratic drug-induced liver injury: long-term follow-up in a hepatotoxicity registry","volume":"44","author":"Andrade","year":"2006","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2012.03.002_bib46","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/art.1780370304","article-title":"Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American College of Rheumatology","volume":"37","author":"Kremer","year":"1994","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.cld.2012.03.002_bib47","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1053\/j.gastro.2009.06.006","article-title":"Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure","volume":"137","author":"Lee","year":"2009","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.cld.2012.03.002_bib48","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1186\/cc3742","article-title":"Science review: carnitine in the treatment of valproic acid-induced toxicity\u2014what is the evidence?","volume":"9","author":"Lheureux","year":"2005","journal-title":"Crit Care"},{"issue":"1","key":"10.1016\/j.cld.2012.03.002_bib49","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.dld.2003.06.002","article-title":"Leflunomide-induced acute hepatitis","volume":"36","author":"Sevilla-Mantilla","year":"2004","journal-title":"Dig Liver Dis"},{"issue":"1","key":"10.1016\/j.cld.2012.03.002_bib50","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s11894-001-0039-y","article-title":"Management of drug-induced liver disease","volume":"3","author":"Marino","year":"2001","journal-title":"Curr Gastroenterol Rep"},{"issue":"1","key":"10.1016\/j.cld.2012.03.002_bib51","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2165\/00002018-200932010-00005","article-title":"Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct","volume":"32","author":"Fontana","year":"2009","journal-title":"Drug Saf"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326112000207?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326112000207?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T16:56:05Z","timestamp":1542992165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326112000207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S1089326112000207"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2012.03.002","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}